Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 42 | 2024 | 706 | 7.160 |
Why?
|
| HIV Envelope Protein gp120 | 21 | 2018 | 139 | 3.910 |
Why?
|
| Viral Tropism | 12 | 2024 | 54 | 3.820 |
Why?
|
| Macrophages | 25 | 2024 | 1000 | 3.560 |
Why?
|
| CD4 Antigens | 18 | 2024 | 154 | 3.500 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 11 | 2024 | 56 | 3.060 |
Why?
|
| HIV Antibodies | 13 | 2024 | 141 | 2.540 |
Why?
|
| HIV Infections | 20 | 2024 | 915 | 1.920 |
Why?
|
| Receptors, CCR5 | 13 | 2018 | 57 | 1.510 |
Why?
|
| Antibodies, Neutralizing | 7 | 2018 | 192 | 1.390 |
Why?
|
| HIV-2 | 7 | 2013 | 23 | 1.340 |
Why?
|
| Brain | 11 | 2018 | 1477 | 1.260 |
Why?
|
| Virus Internalization | 4 | 2017 | 95 | 1.070 |
Why?
|
| Receptors, HIV | 8 | 2012 | 17 | 0.960 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2017 | 137 | 0.930 |
Why?
|
| Virion | 5 | 2017 | 117 | 0.880 |
Why?
|
| HIV | 3 | 2011 | 69 | 0.760 |
Why?
|
| Antibodies, Monoclonal | 5 | 2012 | 864 | 0.680 |
Why?
|
| Simian Immunodeficiency Virus | 3 | 2005 | 79 | 0.650 |
Why?
|
| Polysaccharides | 2 | 2010 | 144 | 0.590 |
Why?
|
| Virus Replication | 9 | 2017 | 297 | 0.590 |
Why?
|
| Cells, Cultured | 12 | 2015 | 2090 | 0.580 |
Why?
|
| CCR5 Receptor Antagonists | 3 | 2007 | 14 | 0.560 |
Why?
|
| Cell Line | 12 | 2018 | 2011 | 0.550 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2015 | 606 | 0.540 |
Why?
|
| AIDS Dementia Complex | 2 | 2006 | 12 | 0.510 |
Why?
|
| Receptors, Virus | 4 | 2018 | 83 | 0.510 |
Why?
|
| Tropism | 2 | 2006 | 17 | 0.490 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 957 | 0.490 |
Why?
|
| HIV Fusion Inhibitors | 3 | 2011 | 9 | 0.480 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2007 | 22 | 0.480 |
Why?
|
| Viral Load | 3 | 2013 | 228 | 0.470 |
Why?
|
| Humans | 46 | 2024 | 58951 | 0.450 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2005 | 63 | 0.450 |
Why?
|
| Virus Cultivation | 3 | 2013 | 17 | 0.450 |
Why?
|
| Preservation, Biological | 1 | 2013 | 6 | 0.430 |
Why?
|
| Molecular Sequence Data | 11 | 2012 | 1972 | 0.420 |
Why?
|
| Virus Attachment | 1 | 2012 | 23 | 0.420 |
Why?
|
| Lymph Nodes | 4 | 2011 | 210 | 0.400 |
Why?
|
| Anti-HIV Agents | 3 | 2007 | 153 | 0.360 |
Why?
|
| Conserved Sequence | 1 | 2010 | 170 | 0.350 |
Why?
|
| Genetic Variation | 3 | 2011 | 367 | 0.350 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2017 | 238 | 0.350 |
Why?
|
| Neutralization Tests | 5 | 2018 | 126 | 0.340 |
Why?
|
| Amino Acid Sequence | 8 | 2010 | 1576 | 0.310 |
Why?
|
| Gene Products, env | 2 | 2006 | 21 | 0.300 |
Why?
|
| Protein Binding | 4 | 2018 | 1542 | 0.290 |
Why?
|
| Codon | 1 | 2007 | 44 | 0.290 |
Why?
|
| Arginine | 1 | 2008 | 113 | 0.290 |
Why?
|
| Detergents | 1 | 2006 | 35 | 0.270 |
Why?
|
| Semen | 1 | 2006 | 42 | 0.260 |
Why?
|
| Gene Products, gag | 1 | 2006 | 65 | 0.260 |
Why?
|
| Specimen Handling | 1 | 2006 | 57 | 0.260 |
Why?
|
| Binding Sites | 3 | 2016 | 872 | 0.250 |
Why?
|
| HeLa Cells | 5 | 2011 | 527 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 458 | 0.250 |
Why?
|
| Peptide Fragments | 3 | 2018 | 350 | 0.250 |
Why?
|
| Receptors, CXCR4 | 5 | 2018 | 32 | 0.230 |
Why?
|
| Protein Conformation | 4 | 2016 | 762 | 0.230 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2004 | 22 | 0.230 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 48 | 0.230 |
Why?
|
| Sequence Alignment | 4 | 2010 | 290 | 0.220 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 438 | 0.220 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 90 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 498 | 0.210 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 251 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 453 | 0.210 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 115 | 0.200 |
Why?
|
| Lentivirus | 1 | 2002 | 54 | 0.200 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2000 | 6 | 0.190 |
Why?
|
| Kidney | 3 | 2008 | 391 | 0.180 |
Why?
|
| Genes, env | 2 | 2017 | 15 | 0.170 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 236 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2011 | 222 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2011 | 304 | 0.150 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 94 | 0.140 |
Why?
|
| AIDS Vaccines | 1 | 2017 | 66 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 82 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2018 | 163 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 177 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2018 | 667 | 0.140 |
Why?
|
| Models, Biological | 4 | 2012 | 1137 | 0.140 |
Why?
|
| Vaccines, DNA | 1 | 2017 | 99 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2016 | 566 | 0.140 |
Why?
|
| Animals | 11 | 2017 | 19516 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2016 | 127 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 450 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 394 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2016 | 265 | 0.120 |
Why?
|
| Human Immunodeficiency Virus Proteins | 2 | 2007 | 7 | 0.120 |
Why?
|
| Gene Expression | 1 | 2018 | 805 | 0.120 |
Why?
|
| Phylogeny | 4 | 2018 | 330 | 0.110 |
Why?
|
| Cloning, Molecular | 2 | 2007 | 384 | 0.110 |
Why?
|
| Mutation | 3 | 2024 | 2420 | 0.100 |
Why?
|
| Adaptation, Biological | 1 | 2012 | 15 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2012 | 68 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2011 | 33 | 0.090 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2011 | 71 | 0.090 |
Why?
|
| London | 1 | 2010 | 12 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 688 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 72 | 0.080 |
Why?
|
| Receptors, CCR3 | 1 | 2009 | 6 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2011 | 461 | 0.080 |
Why?
|
| Receptors, Chemokine | 2 | 2005 | 32 | 0.080 |
Why?
|
| Phenylalanine | 1 | 2008 | 25 | 0.080 |
Why?
|
| Vagina | 1 | 2009 | 82 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 253 | 0.080 |
Why?
|
| HIV Core Protein p24 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2009 | 179 | 0.070 |
Why?
|
| Restriction Mapping | 1 | 2007 | 53 | 0.070 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2007 | 22 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 133 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2008 | 1113 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 357 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 248 | 0.070 |
Why?
|
| Drugs, Investigational | 1 | 2007 | 11 | 0.070 |
Why?
|
| Infant | 2 | 2011 | 1512 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2007 | 120 | 0.070 |
Why?
|
| Viral Envelope Proteins | 1 | 2007 | 107 | 0.070 |
Why?
|
| Adult | 5 | 2018 | 15632 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2006 | 46 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2011 | 1303 | 0.070 |
Why?
|
| Astrocytes | 2 | 2005 | 113 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2006 | 178 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2008 | 489 | 0.070 |
Why?
|
| Microglia | 1 | 2009 | 225 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2007 | 374 | 0.060 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 33 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 335 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 27 | 0.060 |
Why?
|
| Amides | 1 | 2005 | 51 | 0.060 |
Why?
|
| Phenotype | 2 | 2011 | 1151 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2004 | 43 | 0.060 |
Why?
|
| Plague | 1 | 2004 | 23 | 0.060 |
Why?
|
| Neurons | 1 | 2010 | 854 | 0.060 |
Why?
|
| Rabbits | 2 | 2017 | 330 | 0.060 |
Why?
|
| Cysteine | 1 | 2004 | 107 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 11 | 0.060 |
Why?
|
| Chemokine CCL4 | 1 | 2003 | 14 | 0.060 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 10 | 0.050 |
Why?
|
| Monocytes | 1 | 2005 | 350 | 0.050 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2003 | 12 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 50 | 0.050 |
Why?
|
| Benzylamines | 1 | 2003 | 25 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 373 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2004 | 270 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2003 | 95 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 292 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 171 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2003 | 246 | 0.050 |
Why?
|
| Base Sequence | 2 | 2003 | 1309 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 237 | 0.050 |
Why?
|
| Serial Passage | 1 | 2000 | 3 | 0.050 |
Why?
|
| Codon, Initiator | 1 | 2000 | 11 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 2000 | 45 | 0.050 |
Why?
|
| Male | 6 | 2018 | 27335 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 656 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2000 | 228 | 0.040 |
Why?
|
| Pyruvic Acid | 2 | 2010 | 13 | 0.040 |
Why?
|
| Proviruses | 1 | 2018 | 25 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2017 | 20 | 0.040 |
Why?
|
| Indoles | 2 | 2010 | 96 | 0.040 |
Why?
|
| Piperazines | 2 | 2010 | 95 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2017 | 40 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 96 | 0.040 |
Why?
|
| Cell Separation | 1 | 2017 | 147 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 248 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2007 | 114 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 1453 | 0.030 |
Why?
|
| Female | 4 | 2011 | 30625 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 50 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2011 | 46 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 127 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 162 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 70 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 265 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 176 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2009 | 341 | 0.020 |
Why?
|
| Heterozygote | 1 | 2007 | 168 | 0.020 |
Why?
|
| Receptors, CCR6 | 1 | 2005 | 10 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 588 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2007 | 307 | 0.010 |
Why?
|
| Yersinia pestis | 1 | 2004 | 33 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 189 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 10207 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 849 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2004 | 252 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 99 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 176 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2003 | 76 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 880 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 786 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 2881 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 784 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 3168 | 0.010 |
Why?
|